FDA Inspection 1064055 — Evagelos Coskinas, MD, PhD

Evagelos Coskinas, MD, PhD — FEI 3014417795

The FDA completed an inspection of Evagelos Coskinas, MD, PhD on Aug 31, 2018 in Santa Ana, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 31, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Santa Ana, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance